Accelerated Phase Chronic Myeloid Leukemia and Treatment Free Remission Maintained After Five Years of Nilotinib: A Case Report

Accelerated Phase Chronic Myeloid Leukemia and Treatment Free Remission Maintained After Five Years of Nilotinib: A Case Report

The present article reports the case of a patient presenting with chronic myeloid leukemia, diagnosed during the accelerated phase (>20% blasts in peripheral blood samples and megakaryocyte agglomerates in the bone marrow). The subject was treated with first-line therapy with the tyrosine kin...

Full description

Bibliographic Details
Main Authors: Isabella Capodanno, Elisabetta Lugli, Katia Codeluppi, Mariapina Faruolo, Enrica Bellesia, Riccardo Valli, Francesco Merli
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
nilotinib
chronic myeloid leukemia
tyrosine kinase inhibitor
accelerated phase
treatment free remission
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.696253/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.696253/full

Similar Items